Paroxetine EP IMpurity G
| Title | Journal |
|---|---|
| Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API). | Journal of pharmaceutical and biomedical analysis 20081201 |